MedTrace Logo

This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

NCT00996489 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 459

Last updated 2019-07-23

Study results available
· View outcomes & findings →

Summary

This is a post approval study of Coaptite® in the treatment of female urinary incontinence.

Conditions

  • Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

Interventions

DEVICE

Coaptite®

Calcium hydroxylapatite particles suspended in an aqueous based gel carrier

Sponsors & Collaborators

  • Merz North America, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-08
Primary Completion
2015-10-26
Completion
2015-11-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00996489 on ClinicalTrials.gov